Added to YB: 2024-01-05
Pitch date: 2024-01-05
AVRO [bullish]
AVROBIO, Inc.
-4.76%
current return
Author Info
Clark Street Value is a special sits/event-driven investor. Sign up for the newsletter.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
As of June 20, 2024, AVROBIO, Inc. was acquired by Tectonic Therapeutic, Inc., in a reverse merger transaction.
Market Cap
$62.9M
Pitch Price
$17.64
Price Target
2.00 (-88%)
Dividend
N/A
EV/EBITDA
0.58
P/E
2.08
EV/Sales
N/A
Sector
Biotechnology
Category
special_situation
Show full summary:
$AVRO: at least $2/share of value
AVRO strategic review ongoing; $100M NCAV ($2/share) at Q3 less $10M burn; Gaucher program potential kicker to cash value post-Novartis deal for other program; trades $1.32, attractive risk/reward.
Read full article (1 min)